Status:
TERMINATED
Comparison of Three Transfusion Strategies for Central Venous Catheterization in Cirrhotics: A Randomized Clinical Trial
Lead Sponsor:
Hospital Israelita Albert Einstein
Conditions:
Liver Cirrhosis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this study is to compare three different blood transfusion strategies for coagulopathy correction before central venous catheterization in patients with chronic liver failure (cirrhosis and...
Detailed Description
Central venous catheterization is a ubiquitous procedure in intensive care units and is mainly used for drug administration, hemodynamic monitoring and hemodialysis. Only in US more than five million ...
Eligibility Criteria
Inclusion
- Chronic liver failure (cirrhosis or chronic graft dysfunction) from any cause and medical indication of central venous line placement
Exclusion
- Acute liver failure or
- Use of therapeutic doses of oral or parenteral anticoagulants (unfractionated heparin or low molecular weight heparin or oral anticoagulants) or
- Use of oral or parenteral platelet aggregation inhibitors or
- Patients with von Willebrand syndrome or
- Over-the-guidewire central venous catheter changing
- Patients previously included in this study protocol during the same hospital stay
Key Trial Info
Start Date :
September 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2016
Estimated Enrollment :
57 Patients enrolled
Trial Details
Trial ID
NCT02311985
Start Date
September 1 2014
End Date
December 1 2016
Last Update
March 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Israelita Albert Einstein
São Paulo, São Paulo, Brazil, 05652-900